Papcef CV (200+125) Tablet

Papcef CV (200+125) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Alna Biotech. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Clavulanic Acid, Cefpodoxime. This drug comes in the form of Tablet. The general packing available for this medicine consists of 30 Tablet and is priced at Rs 1 020.00 (arround $0.014 US Dollar)
Generic (Salt) Combination :(Clavulanic Acid+ Cefpodoxime)
Pharma Company :Alna Biotech
Brand Label :Papcef CV (200+125)
Preparation Type :Tablet
Single Dose :1 Tablet
Composition (Fixed-Dose Combination) :
  • Cefpodoxime-200 mg
  • Clavulanic Acid-125 mg
Pack Size/Qty/Vol :30 Tablet
Price Unit :Rs 34 INR (arround $0.476 US Dollar)
Price Pack :Rs 1 020.00 INR (arround $0.014 US Dollar)

Drug details for Papcef CV (200+125)

Usage: Why is this medication prescribed?

The main active ingredients or salts in Papcef CV (200+125) are :

  • Cefpodoxime-200 mg
  • Clavulanic Acid-125 mg

Clavulanic Acid
Indication (Prescribed for or used as):

For more details on Clavulanic Acid, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Clavulanic Acid..

Cefpodoxime
Indication (Prescribed for or used as): Cefpodoxime is used to treat certain infections caused by bacteria such as bronchitis (infection of the airway tubes leading to the lungs); pneumonia; gonorrhea (a sexually transmitted disease); and infections of the skin, ear, sinuses, throat, tonsils, and urinary tract. Cefpodoxime is in a class of medications called cephalosporin antibiotics. It works by stopping the growth of bacteria.Antibiotics such as cefpodoxime will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.

URTI including pharyngitis and tonsilitis. Acute exacerbation of chronic bronchitis: Acute community acquired pneumonia: Acute uncomplicated gonorrhoea. Uncomplicated urinary tract infection. Skin infections.

For more details on Cefpodoxime, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Cefpodoxime..

Papcef CV (200+125) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :

There are 9 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Papcef CV (200+125), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Cefpodoxime-200 mg Clavulanic Acid-125 mg).
Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.

BrandPrice (Rs.)BrandPrice (Rs.)
Acepod CA 195Ceftyl CV (200+125) 280
Cumin CV (200+125) 179.95Doxiclav 270
Exlla CV (200+125) 385Frox CVDS 280
Simpod CV 84Stage CV (200+125) 385
Starpod CV (200+125) 168

Search Drug Brands alphabetically